Continuous Positive Airway Pressure (CPAP) and mouthpiece therapy, the primary treatments for sleep apnea syndrome (SAS), offer dramatic improvements. However, many patients struggle to continue treatment due to skin contact discomfort and the inconvenience of wearing devices. Especially in the upcoming summer months, cases of discontinuation due to heat and moisture buildup inside the mask are expected to surge. To uncover the real-life experiences of patients, the General Incorporated Association Snoring & Sleep Apnea Improvement Association conducted a survey of 120 individuals who have undergone SAS treatment. The results revealed that while many patients experience benefits such as reduced snoring and improved daytime alertness, they face significant physical burdens and self-directed interruptions—highlighting the 'barriers to continuation' they encounter.
Survey Background
SAS is a condition that, if left untreated, increases the risk of hypertension, stroke, and serious accidents caused by daytime drowsiness. While treatment effectiveness is extremely high, many patients fail to adapt to the unique environment of sleeping with a device and discontinue therapy. A lack of information—particularly on 'comfortable ways to continue treatment during summer' and 'how to choose the right device'—has become a key stumbling block. This survey aimed to visualize the pain points and overcoming strategies of experienced patients, providing actionable insights to support those currently struggling with treatment or preparing to begin.
Survey Summary
Only 19.2% of respondents reported continuing SAS treatment 'almost every night,' while 42.5% had experienced interruption.
Benefits were widely felt, including 'reduced snoring (39.2%)' and 'improved alertness (33.3%).'
The biggest barrier to continuation was 'inconvenience of wearing the device (48.3%),' followed by 'summer heat and moisture (33.3%).'
When treatment became difficult, one in four (25.0%) respondents 'stopped or reduced use based on self-judgment,' showing a stark divide between self-discontinuation and consulting a doctor.
The key to continuation lies in 'finding the right device and accessories.' Over 30% expressed strong demand for information about devices.
Detailed Data
Q1: How consistently are you currently continuing SAS treatment (CPAP, mouthpiece, etc.)?
Used it temporarily but have since stopped: 42.5%
Using it partially, e.g., several times a week: 21.7%
Using it almost every night, consistently: 19.2%
Switched to another treatment or countermeasure: 8.3%
Prescribed but rarely used: 8.3%
→ Only about one-fifth of respondents continue treatment daily. Approximately 60% have either interrupted treatment or use it only partially, highlighting the high barrier to 'continuation' in SAS therapy.
Q2: After starting SAS treatment, have you felt any noticeable effects?
Told that snoring has decreased: 21.5%
Reduced daytime sleepiness: 18.3%
Waking up refreshed in the morning: 13.7%
Reduced nighttime awakenings: 13.2%
No noticeable effects: 12.3%
Other: 21.0% (feeling of deeper sleep: 11.0%, improved concentration and work efficiency: 5.5%, improved health metrics like blood pressure: 3.7%, etc.)
→ Nearly 80% reported experiencing some benefits. Responses such as 'no longer being told about snoring' and 'reduced daytime sleepiness at work' directly link to improved quality of life (QOL), confirming that treatment effectiveness is highly recognized.
Q3: Do you feel any burden or difficulties while continuing treatment?
Inconvenience of wearing the mask or device: 27.5%
Uncomfortable due to summer heat and moisture: 19.0%
Financial burden (medical visits, rental fees): 14.2%
Difficulty carrying during travel or business trips: 9.5%
Hard to feel benefits, making continuation seem meaningless: 7.6%
Other: 22.2% (noise or air pressure keeps me awake: 7.1%, dryness or skin issues: 6.6%, no burden felt: 4.7%, etc.)
→ Despite benefits, physical stress hinders continuation. Notably, one in three patients finds 'summer heat and moisture' distressing, underscoring the importance of seasonal countermeasures.
Q4: When you felt treatment was 'difficult to continue,' what did you do?
Reduced or stopped use based on self-judgment: 19.7%
Consulted a doctor or medical institution: 19.7%
Endured and continued use: 13.2%
Tried to compensate through lifestyle improvements: 10.5%
Changed device or mask type: 9.9%
Other: 27.0% (never felt it was difficult: 8.6%, searched online for solutions: 7.2%, referred to experiences of others undergoing treatment: 3.9%, etc.)
→ When facing difficulties, 'consulting a medical institution' and 'self-discontinuation' tied at 25.0%, ranking first. Responses were sharply divided between seeking professional help and abandoning treatment alone.
Q5: What advice would you give to someone starting SAS treatment?
It’s important to find a device and mask that suits you: 29.2%
Since benefits come with continuation, I’d encourage them to start: 23.3%
They should know that effectiveness varies by individual: 21.7%
When it’s tough, don’t stop on your own—consult your doctor: 18.3%
Nothing in particular / I don’t know: 7.5%
→ The strongest advice from experienced patients was 'finding the right device.' This reflects a real understanding that rather than enduring discomfort through willpower, improving physical compatibility is the key to long-term adherence.
Q6: What would you like to know or receive support with regarding SAS treatment and continuation?
Information on easy-to-use devices and accessories: 21.3%
Information on financial relief programs: 17.5%
Tips for seasonal use, such as reducing summer moisture: 16.6%
Where to consult when benefits aren’t felt: 13.7%
Experiences from others undergoing the same treatment: 12.8%
Other: 18.1% (lifestyle improvement methods: 10.0%, how to gain family understanding and support: 2.4%, etc.)
→ Patients most desire practical, actionable techniques such as 'information on comfortable devices and accessories' and 'summer usage tips.' Additionally, high demand for financial programs and consultation channels indicates a strong need for practical information and support systems, rather than relying solely on willpower.
Summary of Survey Results
This survey revealed that SAS treatment exists in a strong dilemma between 'high effectiveness' and 'difficult continuation.' Despite most patients recognizing benefits, nearly half discontinue treatment based on self-judgment due to physical discomfort, seasonal factors (summer heat), and financial burden. The key to adherence is not 'endurance,' but rather the flexibility to find a better-fitting mask or accessories, and creating an environment where patients can easily consult doctors or specialists when struggling—this is what the survey suggests.
Comment from the General Incorporated Association Snoring & Sleep Apnea Improvement Association
SAS treatment, especially CPAP, is 'where the real journey begins after starting.' As this survey shows, discomfort from wearing the device or summer heat is not due to patients’ lack of effort—it’s a physical challenge everyone faces. The key is not to give up by thinking 'treatment equals suffering.' Today, mask designs are more diverse, with breathable pads and convenient accessories available to reduce summer moisture. Additionally, beyond CPAP, there are other options such as mouthpiece therapy, surgery, and lifestyle improvements.
FACT BOX
- Source: PR TIMES
- Category: Survey
- Products / services: CPAP